Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (81-90 of 253) with videos related to

Pageof 26
Sort By:
Neuro-Oncology|September 28, 2023
Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effectsCatena Kresbach, Lea Holst, Melanie Schoof, et al.
Klinische Padiatrie|May 12, 2023
[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group]Denise Obrecht, Martin Mynarek, Martina Stickan-Verfürth, et al.
Clinical Neuroradiology|July 21, 2018
MRI Phenotype of RELA-fused Pediatric Supratentorial EpendymomaJohannes Nowak, Stephanie Theresa Jünger, Henner Huflage, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
Journal of Neurosurgery|August 4, 2004
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case reportSteven De Vleeschouwer, Frank Van Calenbergh, Philippe Demaerel, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
The Lancet. Oncology|November 6, 2018
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trialTobias Goschzik, Edward C Schwalbe, Debbie Hicks, et al.
Cancers|December 11, 2022
Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg StudySarah Peters, Sabine Frisch, Annika Stock, et al.
Cancer|December 4, 2009
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocolJohannes E A Wolff, Pablo Hernaiz Driever, Bernhard Erdlenbruch, et al.
Acta Neuropathologica|February 22, 2012
Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstemDaniel Grammel, Monika Warmuth-Metz, André O von Bueren, et al.
Pageof 26

Showing results (81-90 of 253) with videos related to

Sort By:
Pageof 26
Neuro-Oncology|September 28, 2023
Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effectsCatena Kresbach, Lea Holst, Melanie Schoof, et al.
Klinische Padiatrie|May 12, 2023
[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group]Denise Obrecht, Martin Mynarek, Martina Stickan-Verfürth, et al.
Clinical Neuroradiology|July 21, 2018
MRI Phenotype of RELA-fused Pediatric Supratentorial EpendymomaJohannes Nowak, Stephanie Theresa Jünger, Henner Huflage, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
Journal of Neurosurgery|August 4, 2004
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case reportSteven De Vleeschouwer, Frank Van Calenbergh, Philippe Demaerel, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
The Lancet. Oncology|November 6, 2018
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trialTobias Goschzik, Edward C Schwalbe, Debbie Hicks, et al.
Cancers|December 11, 2022
Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg StudySarah Peters, Sabine Frisch, Annika Stock, et al.
Cancer|December 4, 2009
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocolJohannes E A Wolff, Pablo Hernaiz Driever, Bernhard Erdlenbruch, et al.
Acta Neuropathologica|February 22, 2012
Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstemDaniel Grammel, Monika Warmuth-Metz, André O von Bueren, et al.
Pageof 26